John Arena, interim president of global pharma services at Cencora, discusses the importance of engaging with partners as ...

Traditional approaches to HCP segmentation are no longer sufficient. The challenge now is to maintain personalization at ...

According to ZERO Prostate Cancer, Novartis has committed $7.5 million to the initiative.

The campaign is based on the results of a survey that reveals the experiences of patients and caregivers in their communities ...

Under terms of the deal, Stoke will spearhead global development of zorevunersen, while Biogen will receive exclusive rights ...

Valencia will seek to leverage the investment as well as Surek’s leadership experience to drive commercialization of its ...

In this Q&A, Organon's Chief Communications Officer, Becky Edwards discusses how much social media and influencers sway decisions about birth control methods, potential consequences of these ...

In this part of his Pharmaceutical Executive video interview, Ian Chan, CEO of Abpro talks about how collaborations, like the one with Celltrion, have been instrumental in the company's success. Ian ...

John Arena, interim president of global pharma services at Cencora, discusses how companies must prepare for each market and its unique regulatory requirements. Pharmaceutical Executive: What is the ...